{"protocolSection":{"identificationModule":{"nctId":"NCT01277575","orgStudyIdInfo":{"id":"EBS-PP-2010-08-25-001"},"organization":{"fullName":"University of Magdeburg","class":"OTHER"},"briefTitle":"Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia","officialTitle":"Multicenter Study of Non-invasive Repetitive Paraorbital Alternating Current Stimulation of the Brain: Therapy for Aphasy"},"statusModule":{"statusVerifiedDate":"2011-01","overallStatus":"TERMINATED","whyStopped":"recruitment efforts did not result in a sufficient number of patients","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-12"},"primaryCompletionDateStruct":{"date":"2013-12","type":"ACTUAL"},"completionDateStruct":{"date":"2013-12","type":"ACTUAL"},"studyFirstSubmitDate":"2011-01-14","studyFirstSubmitQcDate":"2011-01-14","studyFirstPostDateStruct":{"date":"2011-01-17","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-12-18","lastUpdatePostDateStruct":{"date":"2013-12-19","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Dr. Ephrat Lahmer-Naim, Clinical Trials Manager","oldOrganization":"EBS Technologies GmbH"},"leadSponsor":{"name":"University of Magdeburg","class":"OTHER"},"collaborators":[{"name":"EBS Technologies GmbH","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The investigators assess if repetitive, transcranial alternating current stimulation (rtACS) can improve the speaking quality of the aphasic patient as well as other communication skills as naming, repeating and understanding spoken words, reading and writing. Further, it will be assessed if memory and attentiveness deficiencies after 10 days of therapy with brain stimulation are stabilized and remain stable after a training-free period of 60 days."},"conditionsModule":{"conditions":["Aphasia"],"keywords":["stroke","aphasia","language"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":30,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Verum stimulation","type":"EXPERIMENTAL","description":"repetitive transorbital alternating current stimulation (rtACS)","interventionNames":["Device: rtACS stimulation (Verum condition)"]},{"label":"Placebo stimulation","type":"SHAM_COMPARATOR","description":"Sham stimulation (placebo condition) no intervention","interventionNames":["Device: placebo condition"]}],"interventions":[{"type":"DEVICE","name":"rtACS stimulation (Verum condition)","description":"Repetitive, transorbital alternating current stimulation (rtACS) is applied with multi-channel device generating weak current pulses in predetermined firing bursts of 2 to 9 pulses. The amplitude of each current pulse is below 1000 microA. Current intensity is individually adjusted according to how well patients perceived phosphenes, i.e. any sensation of flickering light in response to the rtACS stimulation","armGroupLabels":["Verum stimulation"]},{"type":"DEVICE","name":"placebo condition","description":"A clicking sound is presented and the same electrode montage set-up is used during rtASC- and Placebo-stimulation, except that placebo patients received no current (stimulator turned off).","armGroupLabels":["Placebo stimulation"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"improvement of speaking","description":"assessed by the following tests:\n\n* Expressive speaking: ANELT (Amsterdam Nijmegen Everyday Language Test), Aachener Aphasie Test\n* receptive speaking: ANELT (Amsterdam Nijmegen Everyday Language Test), Aachener Aphasie Test","timeFrame":"between baseline and 60 days after stimulation"}],"secondaryOutcomes":[{"measure":"successful stabilization of language","timeFrame":"60 days after stimulation"},{"measure":"speaking functions 1 - communicative skills","description":"* reading and writing: Aachener Aphasy Test\n* attentiveness: TAP test battery\n* working Memory: Wechsler Memory scale-Revised (WMS-R)\n* emitional state: Vision Analogous Mood Scale (VAMS)","timeFrame":"baseline to 60 days after stimulation"},{"measure":"speaking functions 2 - spontaneous speech faculty","description":"* reading and writing: Aachener Aphasy Test\n* attentiveness: TAP test battery\n* working Memory: Wechsler Memory scale-Revised (WMS-R)\n* emitional state: Vision Analogous Mood Scale (VAMS)","timeFrame":"baseline to 60 days after stimulation"},{"measure":"speaking functions 3 - naming","description":"* reading and writing: Aachener Aphasy Test\n* attentiveness: TAP test battery\n* working Memory: Wechsler Memory scale-Revised (WMS-R)\n* emitional state: Vision Analogous Mood Scale (VAMS)","timeFrame":"baseline to 60 days after stimulation"},{"measure":"speaking functions 4 - repeating","description":"* reading and writing: Aachener Aphasy Test\n* attentiveness: TAP test battery\n* working Memory: Wechsler Memory scale-Revised (WMS-R)\n* emitional state: Vision Analogous Mood Scale (VAMS)","timeFrame":"baseline to 60 days after stimulation"},{"measure":"speaking functions 5 - understanding","description":"* reading and writing: Aachener Aphasy Test\n* attentiveness: TAP test battery\n* working Memory: Wechsler Memory scale-Revised (WMS-R)\n* emitional state: Vision Analogous Mood Scale (VAMS)","timeFrame":"baseline to 60 days after stimulation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* stroke\n* lesion age at least 6 months\n* aphasia with at least moderate severity according to Aachener Aphasia Test (AAT)\n* age between 40 and 75\n* German-speaking (at a native speaking level)\n\nExclusion Criteria:\n\n* cognitive or speech-language therapy during the 2-weeks stimulation course\n* intensive language training when exceeding 1 hour, 2 times a week during the 2-weeks stimulation course and the follow-up period (60 days after stimulation was completed)\n* additional neurological diseases, e.g. surgical brain tumor removal, untreated tumor disease, acute traumatic brain injury, and/or craniotomy\n* (severe) dysarthria\n* untreated hypertension exceeding 160/100 mmHg (patients with treated hypertension and blood pressure below 160/100 mmHg can be included)\n* increased risk of vascular thrombosis\n* epilepsy, photo sensitivity, acute focal findings (patients without focal findings or epileptiform discharges can be included when they had only a single seizure more than 10 years ago)\n* dementias and neurodegenerative diseases\n* significant psychiatric disturbances, e.g. schizophrenia\n* major attention and/or memory deficits\n* major hearing loss\n* patients with uncorrected visual deficits\n* severe global aphasia\n* modality-specific disorders (pure speech apraxia, pure alexia, pure agraphia)\n* electric or electronic implants (e.g. heart pacemakers)\n* metal artefacts located at the head\n* medication with impact on the central nervous system (e.g. antidepressant or sedative drugs)\n* participation in another trial\n* pregnant or breastfeeding women","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Bernhard A Sabel, Prof. Dr.","affiliation":"University of Magdeburg","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Neurologische Klinik, Medizinische Fakultät der RWTH Aachen, Pauwelsstr. 30","city":"Aachen","zip":"52074","country":"Germany","geoPoint":{"lat":50.77664,"lon":6.08342}},{"facility":"Neurologische Klinik, Brandenburg Klinik Bernau, Brandenburgallee 1","city":"Bernau Waldsiedlung","zip":"16321","country":"Germany"},{"facility":"Institut für Medizinische Psychologie, Leipziger Str. 44","city":"Magdeburg","zip":"39120","country":"Germany","geoPoint":{"lat":52.12773,"lon":11.62916}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001037","term":"Aphasia"}],"ancestors":[{"id":"D000013064","term":"Speech Disorders"},{"id":"D000007806","term":"Language Disorders"},{"id":"D000003147","term":"Communication Disorders"},{"id":"D000019954","term":"Neurobehavioral Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4042","name":"Aphasia","asFound":"Aphasia","relevance":"HIGH"},{"id":"M15554","name":"Speech Disorders","relevance":"LOW"},{"id":"M10513","name":"Language Disorders","relevance":"LOW"},{"id":"M6064","name":"Communication Disorders","relevance":"LOW"},{"id":"M21516","name":"Neurobehavioral Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]}},"hasResults":false}